文献速递炎症性肠病消化内镜消化道肿瘤与早癌

炎症性肠病中晚期病变和结直肠癌内镜监测的依从性:AEG与GETECCU协作队列研究

Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study.
PubMed 文献 · Aliment Pharmacol Ther · 2022-02-27

该回顾性多中心研究纳入2005至2008年诊断、随访至2020年的1031例有结直肠癌监测指征的炎症性肠病患者,评估内镜监测依从性及其对晚期病变的影响。结果显示依从率为27%(95%CI=24-29),依从与晚期病变检出增加相关(HR=3.59;95%CI=1.3-10.1;p=0.016),中、高危组延迟或未行内镜随访的风险高于低危组。

要点

  • 炎症性肠病患者内镜监测依从性仅27%(95%CI=24-29)。
  • 依从监测与晚期病变检出增加相关(HR=3.59;95%CI=1.3-10.1;p=0.016)。
  • 中、高危组较低危组延迟或未行内镜随访风险更高(OR=3.524和OR=4.291)。

核心结论

  • 依从内镜监测可更早发现晚期病变,但依从率低。
  • 结直肠癌风险更高的组别依从性更低。

研究设计与样本

  • 回顾性多中心研究,纳入2005至2008年诊断、随访至2020年的1031例有结直肠癌监测指征的炎症性肠病患者(732例溃疡性结肠炎、259例克罗恩病、40例不确定性结肠炎;平均年龄36±15岁),来自25个西班牙中心。
  • 按欧洲指南将患者分层为风险组,依从定义为按推荐(±1年)进行监测。
  • 采用Cox比例回归分析比较病变风险,p值低于0.05认为显著。

主要发现

  • 内镜筛查在86%的病例中完成。
  • 依从指南率为27%(95%CI=24-29)。
  • 晚期病变和结直肠癌分别检出38例(4%)和7例(0.7%)。
  • 依从与晚期病变检出增加相关(HR=3.59;95%CI=1.3-10.1;p=0.016)。
  • 延迟或未行内镜随访的风险随风险组升高而增加:中危组 vs 低危组 OR=3.524(95%CI=2.462-5.044;p<0.001),高危组 vs 低危组 OR=4.291(95%CI=2.409-7.644;p<0.001)。

关键数值与推荐

  • 依从定义:按欧洲指南推荐进行监测(±1年)。
  • 依从率27%(95%CI=24-29)。
  • 依从 vs 不依从的晚期病变检出 HR=3.59(95%CI=1.3-10.1;p=0.016)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients with colonic inflammatory bowel disease (IBD) have a high risk of colorectal cancer (CRC). Current guidelines recommend endoscopic surveillance, yet epidemiological studies show poor compliance. The aims of our study were to analyse adherence to endoscopic surveillance, its impact on advanced colorectal lesions, and risk factors of non-adherence. METHODS: A retrospective multicentre study of IBD patients with criteria for CRC surveillance, diagnosed between 2005 and 2008 and followed up to 2020, was performed. Following European guidelines, patients were stratified into risk groups and adherence was considered when surveillance was performed according to the recommendations (±1 year). Cox-proportional regression analyses were used to compare the risk of lesions. p-values below 0.05 were considered significant. RESULTS: A total of 1031 patients (732 ulcerative colitis, 259 Crohn's disease and 40 indeterminate colitis; mean age of 36 ± 15 years) were recruited from 25 Spanish centres. Endoscopic screening was performed in 86% of cases. Adherence to guidelines was 27% (95% confidence interval, CI = 24-29). Advanced lesions and CRC were detected in 38 (4%) and 7 (0.7%) patients respectively. Adherence was associated with increased detection of advanced lesions (HR = 3.59; 95% CI = 1.3-10.1; p = 0.016). Risk of delay or non-performance of endoscopic follow-up was higher as risk groups increased (OR = 3.524; 95% CI = 2.462-5.044; p < 0.001 and OR = 4.291; 95%CI = 2.409-7.644; p < 0.001 for intermediate- and high- vs low-risk groups). CONCLUSIONS: Adherence to endoscopic surveillance allows earlier detection of advanced lesions but is low. Groups at higher risk of CRC are associated with lower adherence.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Ballester MP, Mesonero F, Flórez-Diez P, et al. Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study. Aliment Pharmacol Ther. 2022. PMID: 35224758. doi:10.1111/apt.16832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。